As per Intent Market Research, the Pressure Ulcers Treatment Market was valued at USD 4.8 billion in 2024-e and will surpass USD 7.9 billion by 2030; growing at a CAGR of 8.7% during 2025 - 2030.
The pressure ulcers treatment market has seen steady growth, driven by the increasing prevalence of pressure ulcers among patients who are bedridden, elderly, or suffering from chronic conditions. Pressure ulcers, commonly known as bedsores, are a significant healthcare concern as they result in discomfort, extended hospital stays, and higher medical costs. The demand for effective treatments, including topical treatments, dressings, surgical options, and medication, is rapidly increasing in hospitals, long-term care facilities, and home care environments. Healthcare providers are increasingly focused on improving patient outcomes by utilizing advanced treatment methods to prevent and manage pressure ulcers, which can have serious complications if left untreated.
The market is characterized by ongoing innovations in treatment options, with an emphasis on improving wound healing and minimizing the risk of infection. Advances in medical technologies and products designed for both acute and chronic pressure ulcer management are expected to drive further growth. With the rising aging population, increased awareness, and a push for better patient care, the market for pressure ulcer treatments continues to expand, particularly in institutional settings like hospitals and long-term care facilities. These factors contribute to the growing demand for both preventive and therapeutic pressure ulcer treatments.
Topical Treatments Segment is Largest Owing to Accessibility and Effectiveness
The topical treatments segment is the largest in the pressure ulcers treatment market, driven by the accessibility, ease of application, and effectiveness of these treatments in managing pressure ulcers. Topical treatments, which include ointments, creams, and gels, are widely used in both hospital and home care settings. These treatments aim to promote healing by keeping the wound moist, preventing infection, and reducing inflammation. Many topical treatments also contain antimicrobial agents that help in preventing or managing infections, a common complication in pressure ulcer cases.
The popularity of topical treatments can be attributed to their ability to be applied directly to the wound site without the need for advanced medical intervention. They are relatively affordable compared to surgical treatments and medications, making them a preferred option for treating early-stage pressure ulcers. Additionally, topical treatments are effective for managing both acute and chronic wounds, further contributing to their dominance in the market. The ongoing development of new formulations designed to speed up healing and enhance comfort will likely continue to support the growth of the topical treatments segment in the pressure ulcers treatment market.
Dressings Segment is Fastest Growing Owing to Advanced Wound Healing Properties
The dressings segment is the fastest growing in the pressure ulcers treatment market, propelled by the increasing demand for specialized wound care products that enhance the healing process. Modern dressings, including hydrocolloid, foam, and alginate dressings, are designed to create optimal healing conditions by maintaining a moist environment and offering superior protection against infection. These advanced dressings not only support faster healing but also provide comfort and reduce pain, which is particularly important for patients who are already dealing with the discomfort associated with pressure ulcers.
As the awareness of the importance of proper wound management grows, healthcare providers are increasingly adopting advanced dressing products that help prevent complications and ensure better outcomes. The rapid development of smart and bioactive dressings that can absorb exudate, deliver medication, and even monitor wound conditions is driving the demand for dressings. As a result, this segment is expected to see significant growth in the coming years, especially in hospital and long-term care settings, where pressure ulcers are more prevalent, and patients are in need of efficient, high-performance products.
Hospitals Segment is Largest End-User Owing to High Incidence of Pressure Ulcers in Critical Care
The hospitals segment is the largest end-user in the pressure ulcers treatment market, owing to the high incidence of pressure ulcers among hospitalized patients. Hospitals are where the majority of pressure ulcers are treated, particularly for individuals who are undergoing surgeries or have long-term conditions such as stroke, spinal injuries, or other ailments that result in immobility. Pressure ulcers are a common complication in these patients, and hospitals are crucial in providing the necessary treatment to prevent and manage these wounds effectively.
Hospital-based treatment methods include a combination of topical treatments, advanced dressings, medications, and, in some cases, surgical interventions. The high volume of patients, along with the growing focus on improving patient care and reducing hospital-acquired conditions, ensures that hospitals will continue to be the largest end-user for pressure ulcer treatments. As the prevalence of pressure ulcers remains high, hospitals are increasingly investing in advanced products and treatment techniques to ensure better care and faster healing for their patients.
Retail Pharmacies Segment is Fastest Growing Distribution Channel Owing to Convenience and Accessibility
The retail pharmacies segment is the fastest growing distribution channel in the pressure ulcers treatment market, primarily due to the increasing shift toward at-home care and the convenience of purchasing over-the-counter treatments. Patients and caregivers can easily access pressure ulcer treatment products like topical treatments, dressings, and medication from retail pharmacies, reducing the need for hospital visits. With the growing adoption of home care for managing pressure ulcers, retail pharmacies are playing an increasingly important role in providing accessible and affordable treatment options.
The availability of a wide range of pressure ulcer treatment products in retail pharmacies, including both prescription and over-the-counter options, contributes to the market’s growth. Additionally, retail pharmacies often offer professional advice on wound care, helping customers make informed decisions about their treatment options. As patients increasingly manage their pressure ulcer treatment in home care settings, the retail pharmacies segment is expected to continue expanding, driven by the demand for easy-to-use, effective products.
Acute Pressure Ulcers Application Segment is Largest Owing to High Incidence and Urgent Need for Treatment
The acute pressure ulcers application segment is the largest in the pressure ulcers treatment market, driven by the high incidence of acute pressure ulcers, particularly in hospitalized patients or those undergoing surgery. Acute pressure ulcers are typically caused by prolonged pressure on the skin, which restricts blood flow and leads to tissue damage. These ulcers can develop rapidly, especially in patients with limited mobility, making it crucial to treat them promptly to avoid further complications. Acute pressure ulcers are often treated with a combination of topical treatments, dressings, and medications, with the goal of healing the wound and preventing infection.
As acute pressure ulcers are a common complication in healthcare settings, particularly in hospitals and intensive care units (ICUs), the demand for effective treatments in this area remains high. The need for immediate intervention to treat acute wounds and promote healing ensures that this application segment remains the largest in the pressure ulcers treatment market. Furthermore, advancements in wound care technologies are helping to accelerate healing and reduce complications, contributing to the ongoing growth of the acute pressure ulcers application segment.
North America is Largest Region Owing to Advanced Healthcare Systems and High Prevalence of Pressure Ulcers
North America is the largest region in the pressure ulcers treatment market, owing to the advanced healthcare infrastructure, the high prevalence of pressure ulcers, and the increasing demand for effective wound care treatments. The United States, in particular, has a well-established healthcare system that provides comprehensive treatment options for pressure ulcers in hospitals, long-term care facilities, and home care settings. The aging population and the rising number of individuals with chronic conditions that lead to immobility are contributing to the higher incidence of pressure ulcers, further driving demand for treatment solutions.
In addition to the robust healthcare infrastructure, the region benefits from a high level of awareness regarding the importance of early detection and treatment of pressure ulcers, which is leading to better outcomes for patients. The availability of a wide range of products, including advanced dressings, topical treatments, and medications, ensures that patients in North America have access to the best treatment options available. As a result, North America remains the dominant region in the pressure ulcers treatment market.
Competitive Landscape
The pressure ulcers treatment market is highly competitive, with numerous global and regional players offering a wide range of products to meet the growing demand for effective wound care solutions. Leading companies in this market include Smith & Nephew, Mölnlycke Health Care, 3M, and ConvaTec, which offer advanced treatments such as hydrocolloid and foam dressings, as well as topical treatments and medications. These companies continue to innovate by developing new products that improve the healing process and reduce infection risks.
Smaller, specialized players are also emerging in the market, focusing on specific treatment types or targeting niche markets with unique solutions. As the market grows, competition is expected to intensify, with companies focusing on enhancing product performance, expanding their distribution channels, and ensuring affordability to maintain a competitive edge. The increasing trend of home care and the growing awareness of pressure ulcer management will also drive companies to develop user-friendly products for both healthcare professionals and caregivers.
List of Leading Companies:
- Smith & Nephew
- ConvaTec
- Molnlycke Health Care
- Acelity (KCI Medical)
- Medtronic
- 3M
- Hollister Incorporated
- Integra LifeSciences
- Baxter International
- Paul Hartmann AG
- DermaRite Industries
- Derma Sciences, Inc.
- Essity
- Medline Industries
- Coloplast
Recent Developments:
- In December 2024, Smith & Nephew launched an advanced hydrocolloid dressing designed to accelerate healing in chronic pressure ulcers.
- In November 2024, Molnlycke Health Care introduced a new foam dressing aimed at reducing pain and promoting faster wound healing in pressure ulcers.
- In October 2024, ConvaTec announced the release of an antimicrobial wound care solution to combat infections in pressure ulcers.
- In September 2024, Medtronic unveiled an upgraded negative pressure wound therapy device, improving suction power and efficiency in pressure ulcer treatment.
- In August 2024, 3M expanded its wound care product range with a new ointment-based treatment for pressure ulcers, enhancing skin regeneration.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 4.8 billion |
|
Forecasted Value (2030) |
USD 7.9 billion |
|
CAGR (2025 – 2030) |
8.7% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Pressure Ulcers Treatment Market By Treatment Type (Topical Treatments, Dressings, Surgical Treatments, Medication), By Distribution Channel (Retail Pharmacies, Online Sales, Hospitals), By Application (Acute Pressure Ulcers, Chronic Pressure Ulcers, Post-Surgical Wounds, Traumatic Pressure Ulcers), By End-User (Hospitals, Long-Term Care Facilities, Home Care Providers, Rehabilitation Centers) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
Smith & Nephew, ConvaTec, Molnlycke Health Care, Acelity (KCI Medical), Medtronic, 3M, Hollister Incorporated, Integra LifeSciences, Baxter International, Paul Hartmann AG, DermaRite Industries, Derma Sciences, Inc., Essity, Medline Industries, Coloplast |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Pressure Ulcers Treatment Market, by Treatment Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Topical Treatments |
|
4.1.1. Gel-based Treatments |
|
4.1.2. Cream-based Treatments |
|
4.1.3. Ointment-based Treatments |
|
4.2. Dressings |
|
4.2.1. Hydrocolloid Dressings |
|
4.2.2. Alginate Dressings |
|
4.2.3. Foam Dressings |
|
4.2.4. Transparent Film Dressings |
|
4.3. Surgical Treatments |
|
4.3.1. Skin Grafts |
|
4.3.2. Flap Surgery |
|
4.4. Medication |
|
4.4.1. Antibiotics |
|
4.4.2. Pain Management Medications |
|
5. Pressure Ulcers Treatment Market, by Distribution Channel (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Retail Pharmacies |
|
5.2. Online Sales |
|
5.3. Hospitals |
|
5.4. Others |
|
6. Pressure Ulcers Treatment Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Acute Pressure Ulcers |
|
6.2. Chronic Pressure Ulcers |
|
6.3. Post-Surgical Wounds |
|
6.4. Traumatic Pressure Ulcers |
|
7. Pressure Ulcers Treatment Market, by End-User (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Hospitals |
|
7.2. Long-Term Care Facilities |
|
7.3. Home Care Providers |
|
7.4. Rehabilitation Centers |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Pressure Ulcers Treatment Market, by Treatment Type |
|
8.2.7. North America Pressure Ulcers Treatment Market, by Distribution Channel |
|
8.2.8. North America Pressure Ulcers Treatment Market, by Application |
|
8.2.9. North America Pressure Ulcers Treatment Market, by End-User |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Pressure Ulcers Treatment Market, by Treatment Type |
|
8.2.10.1.2. US Pressure Ulcers Treatment Market, by Distribution Channel |
|
8.2.10.1.3. US Pressure Ulcers Treatment Market, by Application |
|
8.2.10.1.4. US Pressure Ulcers Treatment Market, by End-User |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. Smith & Nephew |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. ConvaTec |
|
10.3. Molnlycke Health Care |
|
10.4. Acelity (KCI Medical) |
|
10.5. Medtronic |
|
10.6. 3M |
|
10.7. Hollister Incorporated |
|
10.8. Integra LifeSciences |
|
10.9. Baxter International |
|
10.10. Paul Hartmann AG |
|
10.11. DermaRite Industries |
|
10.12. Derma Sciences, Inc. |
|
10.13. Essity |
|
10.14. Medline Industries |
|
10.15. Coloplast |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Pressure Ulcers Treatment Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Pressure Ulcers Treatment Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.jpg)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Pressure Ulcers Treatment Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA